Avenin fails to induce a TH1 response in coeliac tissue following in vitro culture

Gut

Volumn 52, Issue 1, 2003, Pages 47-52

  Kilmartin, C ^a   Lynch, S ^a   Abuzakouk, M ^a   Wieser, H ^b   Feighery, C ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AVENIN; CYTOKINE; GAMMA INTERFERON; GLIADIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; TAQ POLYMERASE;

ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUODENUM BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; OAT; ORGAN CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA EXTRACTION; TH1 CELL; TISSUE CULTURE;

ADULT; AVENA SATIVA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; CYTOKINES; DUODENUM; FEMALE; GLIADIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PLANT PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TH1 CELLS;

EID: 0037214333     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.1.47     Document Type: Article

References (42)

1. Dicke WK, Weijers HA, van de Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 1953;42:34-42
2. van de Kamer JN, Weijers HA, Dicke WK. Coeliac Disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 1953;42:223-31.
3. Baker PG, Read AE. Oats and barley toxicity in coeliac patients. Postgrad Med J 1976;52:264-8.
4. Moulton ALC. The place of oats in the coeliac diet. Arch Dis Child 1959;34:51-5.
5. Dissanayake AS, Truelove SC, Whitehead R. Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. BMJ 1974;4:189-91.
6. Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033-7.
7. Srinivasan U, Leonard N, Jones E, et al. Absence of oats toxicity in adult coeliac disease. BMJ 1996;313:1300-1.
8. Hoffenberg EJ, Haas J, Drescher A, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr 2000;137:361-6.
9. Srinivasan U, Jones E, Weir DG, et al. Lactase enzyme, detected immunohistochemically, is lost in active coeliac disease but unaffected by oats challenge. Am J Gastroenterol 1999;94:2936-41.
10. Janatuinen EK, Kemppainen TA, Pikkarainen PH, et al. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000;46:327-31.
11. Janatuinen EK, Kemppainen TA, Julkunen RJ, et al. No harm from five year ingestion of oats in coeliac disease. Gut 2002;50:332-5.
12. Hardman CM, Garioch JJ, Leonard JN, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997;337:1884-7.
13. Reunala T, Collin P, Holm K, et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998;43:490-3.
14. Picarelli A, Di Tola M, Sabbatella L, et al. Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr 2001;74:137-40.
15. Leone NA, Mazzarella G, Ciacci C, et al. Oats prolamines in vitro activate intestinal cell-mediated immunity in coeliac disease. In: Collin P, Mäki M, eds. Abstracts of the Seventh International Symposium on Coeliac Disease, 1996 Sept 5-7. Tampere, Finland Tampere: Lege Antis, 1996.
16. Nilsen EM, Jahnsen FL, Lundin KE, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998;115:551-63.
17. Allmann M, Candrian U, Hofelein C, et al. A possible alternative to immunochemical methods assuring safety and quality of food. Detection of wheat contamination in non-wheat food products. Z Lebensm Unters Forsch 1993; 196:248-51.
18. Bolte G, Osman A, Mothes T, et al. Peptic tryptic digests of gliadin: Contaminating trypsin but not pepsin interferes with gastrointestinal protein binding characteristics. Clin Chim Acta 1996; 247:59-70.
19. Müller S, Wieser H. The location of disulphide bonds in α-type gliadins. J Cereal Sci 1995; 22:21-7.
20. Browning TH, Trier JS. Organ culture of mucosal biopsies of human small intestine. J Clin Invest 1969;48:1423-32.
21. Mac Donald RJ, Swift GH, Przybyla AE, et al. Isolation of RNA using guanidium salts. Methods Enzymol 1987;152:219-27.
22. Maiuri L, Picarelli A, Boirivant M, et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996;110:1368-78.
23. Sturgess RP, Hooper LB, Spencer J, et al. Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol 1992;27:907-11.
24. Ishii N, Chiba M, Iizuka M, et al. Induction of HLA-DR antigen expression on human colonic epithelium by tumor necrosis factor-alpha and interferon-gamma. Scand J Gastroenterol 1994;29:903-7.
25. Paolieri F, Battifora M, Riccio AM, et al. Intercellular adhesion molecule-1 on cultured human epithelial cell lines: Influence of proinflammatory cytokines. Allergy 1997;52:521-31.
26. Kaiserlian D, Rigal D, Abello J, et al. Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 1991 ;21:2415-21.
27. Przemioslo RT, Kontakou M, Nobili V, et al. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry. Gut 1994;35:1398-403.
28. Maiuri L, Ciacci C, Salvatore A, et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000;119:996-1006.
29. Kontakou M, Sturgess RP, Przemioslo RT, et al. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridization. Gut 1994;35:1037-41.
30. Kontakou M, Przemioslo RT, Sturgess RP, et al. Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol 1995;30:456-63.
31. Lahat N, Shapiro S, Karban A, et al. Cytokine profile in coeliac disease. Scand J Immunol 1999;49:441-6.
32. Troncone R, Gianfrani C, Mazzarella G, et al. Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-γ and interleukin-4. Dig Dis Sci 1998;43:156-61.
33. Przemioslo RT, Lundin KE, Sollid LM, et al. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon γ antibody. Gut 1995;36:874-9.
34. Nilsen EM, Lundin KE, Krajci P, et al. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produces cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 1995;37:766-76.
35. O'Keeffe J, Mills K, Jackson J, et al. T cell proliferation, MHC II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 1999;117:269-76.
36. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-42.
37. D'Elios M, Del Prete G. Th1/Th2 balance in human disease. Transplant Proc 1998;30:2373-7.
38. Howdle PD, Corazza GR, Bullen AW, et al. Gluten sensitivity of small intestinal mucosa in vitro: Quantitative assessment of histologic change. Gastroenterology 1981;80:442-50.
39. Fluge G, Aksnes L. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. Scand J Gastroenterol 1981;16:555-67.
40. Maiuri L, Troncone R, Mayer M, et al. In vitro activities of A-gliadin-related synthetic peptides. Scand J Gastroenterol 1996;31:247-53.
41. Shidrawi RG, Day P, Przemioslo R, et al. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995;30:758-63.
42. Hardman C, Fry L, Tatham A, et al. Absence of toxicity of avenin in patients with dermatitis herpetiformis. N Eng J Med 1999;340:321.